BioSpace News Archive

Race executes worldwide license agreement with City of Hope, one of the largest cancer research and treatment organisations in the United States.

Biodexa Ltd is pleased to announce completion of enrolment and treatment of nine paediatric patients into the ongoing investigator-sponsored Phase I study of MTX-110 in newly diagnosed DMGs (NCT 04264143).

MBX Biosciences, Inc. today announced the appointment of Steven Prestrelski, Ph.D., M.B.A., as Chief Scientific Officer (CSO).

Paratek Pharmaceuticals, Inc. today announced a modification to its Project BioShield contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services.

Longeveron Inc. announced today that Chairman, Co-founder and Chief Science Officer Joshua Hare, MD, FACC, has been inducted as a fellow of the prestigious National Academy of Inventors (NAI) in recognition of his leading-edge research and development of stem cell therapies for heart disease.

Galmed Pharmaceuticals Ltd. is delighted to announce the first step in its strategic partnership with OnKai, where OnKai will apply its artificial intelligence (AI), models for enrollment and execution of clinical trials in underserved communities, starting with Galmed’s innovative Primary Sclerosing Cholangitis (PSC) clinical development program.

Zoetis Inc. (NYSE:ZTS) today announced the addition of Ester Banque as Executive Vice President and President, U.S. Operations, for the company, effective July 10, 2023.

Normunity, Inc today announced the appointment of Debanjan Ray, MBA, to its board of directors.

Fresenius Kabi announced it has launched Ganirelix Acetate Injection, a generic fertility drug, as part of the company’s expansion in women’s health.

UroGen Pharma Ltd. today highlights the results of a sub-analysis from the first post-commercial utilization review of JELMYTO (mitomycin) for pyelocalyceal solution.